Want to see TECH full AI Analyst Report?
Total Valuation
Bio-Techne has a market cap or net worth of $11.33B. The enterprise value is $11.12K.
Market Cap$11.33B
Enterprise Value$11.12K
Share Statistics
Bio-Techne has 156,568,760 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding156,568,760
Owned by Insiders0.32%
Owned by Institutions13.35%
Financial Efficiency
Bio-Techne’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 7.81%.
Return on Equity (ROE)0.09
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)7.81%
Return on Capital Employed (ROCE)0.10
Revenue Per Employee391.95K
Profits Per Employee58.67K
Employee Count3,100
Asset Turnover0.47
Inventory Turnover2.13
Valuation Ratios
The current PE Ratio of Bio-Techne is 61.9. Bio-Techne’s PEG ratio is 0.41.
PE Ratio61.9
PS Ratio9.07
PB Ratio5.23
Price to Fair Value5.23
Price to FCF41.86
Price to Operating Cash Flow38.62
PEG Ratio0.41
Income Statement
In the last 12 months, Bio-Techne had revenue of 1.22B and earned 181.86M in profits. Earnings per share was 1.17.
Revenue1.22B
Gross Profit799.07M
Operating Income251.89M
Pretax Income240.68M
Net Income181.86M
EBITDA343.44M
Earnings Per Share (EPS)1.17
Cash Flow
In the last 12 months, operating cash flow was 292.07M and capital expenditures -28.85M, giving a free cash flow of 263.22M billion.
Operating Cash Flow292.07M
Free Cash Flow263.22M
Free Cash Flow per Share1.68
Dividends & Yields
Bio-Techne pays an annual dividend of $0.08, resulting in a dividend yield of 0.44%
Dividend Per Share$0.08
Dividend Yield0.44%
Payout Ratio16.49%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change32.22%
50-Day Moving Average67.72
200-Day Moving Average60.08
Relative Strength Index (RSI)69.07
Average Volume (3m)6.36M
Important Dates
Bio-Techne upcoming earnings date is Nov 3, 2026, Before Open (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 3, 2026
Ex-Dividend Date―
Financial Position
Bio-Techne as a current ratio of 4.55, with Debt / Equity ratio of 13.00%
Current Ratio4.55
Quick Ratio3.35
Debt to Market Cap0.02
Net Debt to EBITDA0.07
Interest Coverage Ratio46.60
Taxes
In the past 12 months, Bio-Techne has paid 58.82M in taxes.
Income Tax58.82M
Effective Tax Rate0.24
Enterprise Valuation
Bio-Techne EV to EBITDA ratio is 32.15, with an EV/FCF ratio of 41.95.
EV to Sales9.09
EV to EBITDA32.15
EV to Free Cash Flow41.95
EV to Operating Cash Flow37.81
Balance Sheet
Bio-Techne has $264.71M in cash and marketable securities with $274.15M in debt, giving a net cash position of -$9.44M billion.
Cash & Marketable Securities$264.71M
Total Debt$274.15M
Net Cash-$9.44M
Net Cash Per Share-$0.06
Tangible Book Value Per Share-$2.88
Margins
Gross margin is 65.77%, with operating margin of 20.73%, and net profit margin of 14.97%.
Gross Margin65.77%
Operating Margin20.73%
Pretax Margin19.81%
Net Profit Margin14.97%
EBITDA Margin28.27%
EBIT Margin20.25%
Analyst Forecast
The average price target for Bio-Techne is $72.11, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$72.11
Price Target Upside0.71% Upside
Analyst ConsensusHold
Analyst Count11
Revenue Growth Forecast-0.38%
EPS Growth Forecast152.69%